AAV Packaging Test and ProAAV Manufacturing
Cost-effective AAV feasibility testing and ProAAV vector production for non-clinical studies.
Fast, Scalable GMP Plasmid Manufacturing for Advanced Therapies
Guaranteed Delivery
Deliver up to ~1 mL AAV from just 200 μL, with robust ROA.
Industry Leading Timeline
Accelerate development with rapid turnaround time, with AAV production from plasmid construction in just 6 weeks.
Scalability with Quality
From development to scale: ~1 L working volume with AC/AEX purification.
ProAAV: End-to-End AAV Production Workflow
Case Studies
PowerS™-293 Delivers High AAV Titers Across Multiple Serotypes, Enabling Flexible Gene Therapy Development
PowerS™-293 Outperforms Competitor Cell Line with Higher Cell Density, Viability, and Growth Performance for AAV Manufacturing
Resources
FLYER
GMP AAV Plasmid Manufacturing
Scale up your AAV plasmid production with phase-appropriate quality grades, analytics, and regulatory support.
POSTER
PowerS™-ITRrs Strain Suitable for Different AAV Transfer Plasmids
Learn more about how the proprietary PowerS™-ITRrs strain delivers high performance with consistent results.
FLYER
GMP Viral Vector Manufacturing
Your programs are important, and your time is valuable. ProBio is a responsive and reliable CDMO partner of viral vector for pre-clinical, clinical and commercial use.
FLYER
Viral Vector Packaging Test - Seamless Transition from Discovery to CMC
This flyer showcases ProBio’s Viral Vector Packaging Test with seamless discovery-to-CMC compatibility, covering LVV, in vivo CAR-T tLVV and AAV.
Frequently Asked Questions